Research and Development of New Antimalarial Medicines Project

Research and development of new antimalarial medicines and building capacity in pharmacovigilance in sub-Saharan Africa.

Sanofi and MMV Partnership

Sanofi and the Medicines for Malaria Venture (MMV) collaborate in the research and development of new antimalarial medicines, and in building capacity in pharmacovigilance in sub-Saharan Africa. In 2011 both parties agreed to work together to identify, characterize and optimize new candidate compounds. This three-year research project agreement, called “Orthology Malaria,” aims to develop drug candidates from a set of Sanofi’s compounds that have been selected for their potential activity against malaria parasites. Each stage of the project will be evaluated by the Sanofi–MMV Joint Steering Committee and assessed according to MMV’s criteria for compound progression.

Partnership objectives:

  • Collaborate in the research and development of new antimalarial drugs.
  • Contribute to build capacity in pharmacovigilance in sub-saharan Africa.


  • Sanofi

    Goods Supplier
    Canada | Staff size: Unknown

    Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi engages in the research and development,...

  • Ministry of Health and the Fight against HIV/AIDS

    Cote d Ivoire | Staff size: Unknown

    The main goal of the Ministry of Health is to provide and continually improve the health services of Cote d'Ivoire through the provision of preventive, curative and rehabilitative health care...

  • Drugs for Neglected Diseases Initiative (DNDi)

    United States | Staff size: 251-500

    Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is...

  • Medicines for Malaria Venture (MMV)

    Staff size: 101-250

    MMV is a not-for-profit public-private partnership established as a foundation in Switzerland in 1999. Its mission is to reduce the burden of malaria in disease-endemic countries by discovering,...

  • National Malaria Control Programme (NMCP)

    Nigeria | Staff size: Unknown

    Globally, millions of deaths attributable to malaria are still being recorded. The disease constitutes a huge epidemiologic burden in Africa and continues to cripple the economic development in...

More Resources

Key Information

LocationEast Asia and Pacific, South Asia, Latin America and Caribbean, Eastern Africa
  • Start Date 2008